| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |